Latest Breaking News On - Liu peicheng - Page 3 : comparemela.com
Sinovac says vaccine effective against Delta variant | The Malaysian Insight
themalaysianinsight.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themalaysianinsight.com Daily Mail and Mail on Sunday newspapers.
Southeast Asia turning away from Chinese vaccines as delta variant surges
telegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegraph.co.uk Daily Mail and Mail on Sunday newspapers.
Sinopharm vaccine approved to treat children, teenagers By WANG XIAOYU | CHINA DAILY | Updated: 2021-07-20 07:30 Share CLOSE A medical worker injects a dose of COVID-19 vaccine to a local resident in Ruili, Southwest China s Yunnan province, April 1, 2021. [Photo/Xinhua]
Sinopharm s COVID-19 vaccine has been approved for emergency use for young people ages 3 to 17, after early and midstage clinical trials showed it is safe and can elicit strong immune responses in the age group, the company said in a recent statement.
The approval was granted by the Joint Prevention and Control Mechanism of the State Council, which was set up to deal with the COVID-19 pandemic.
Women and a child walk by a billboard calling on people to get vaccinated against Covid-19 outside a shopping mall in Beijing, capital of China, on May 24, 2021. - AP
BEIJING (China Daily/ANN): Sinopharm s Covid-19 vaccine has been approved for emergency use for young people ages 3 to 17, after early and midstage clinical trials showed it is safe and can elicit strong immune responses in the age group, the company said in a recent statement.
The approval was granted by the Joint Prevention and Control Mechanism of the State Council, which was set up to deal with the Covid-19 pandemic.
It is the second domestic Covid-19 vaccine made available for children and teenagers in China. In June, Sinovac Biotech s vaccine was authorised for emergency use for young people.
Friday, 16 Jul 2021 08:14 AM MYT
A medical worker takes a box of Sinovac’s vaccine against the coronavirus disease from a refrigerator at a community health centre in Qingdao, Shandong province, China January 5, 2021. China Daily pic via Reuters
Follow us on Instagram and subscribe to our Telegram channel for the latest updates.
SANTIAGO, July 16 The leaders of a Chilean late-stage human trial of the CoronaVac Covid-19 vaccine developed by China’s Sinovac on Thursday recommended a third dose of the jab to protect against the more contagious Delta variant.
The trial leaders said a separate in vitro laboratory trial to determine the vaccine’s effectiveness against the Delta strain of the virus showed that neutralising antibodies reduced four-fold compared to those produced against the original coronavirus strain first found in China.
vimarsana © 2020. All Rights Reserved.